AbbVie Inc.
BICYCLIC PYRAZOLE BRUTON'S TYROSINE KINASE INHIBITORS
Last updated:
Abstract:
The present invention provides for compounds of formula (I) ##STR00001## wherein A, R.sup.1, R.sup.2, R.sup.4, W, m, and n have any of the values defined herein, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of CLL and/or SLL.
Status:
Application
Type:
Utility
Filling date:
16 Dec 2021
Issue date:
7 Jul 2022